prikaz prve stranice dokumenta Auditing HIV testing rates across Europe: results from the HIDES 2 Study
  Preuzmi
PDF 286.81 KB
Znanstveni rad - Izvorni znanstveni rad
Auditing HIV testing rates across Europe: results from the HIDES 2 Study
PLoS ONE, 10 (2015), 11; e0140845. https://doi.org/10.1371/journal.pone.0140845
Raben, D.; Mocroft, A.; Rayment, M.; Mitsura, V. M.; Hadziosmanovic, V.; Sthoeger, Z. M.; Palfreeman, A.; Morris, S.; Kutsyna, G.; Vassilenko, A.; Minton, J.; Necsoi, C.; Estrada, V. P.; Grzeszczuk, A.; Svedhem Johansson, V.; Begovac, Josip; Ong, E. L. C.; Cabié, A.; Ajana, F.; Celesia, B. M.; Maltez, F.; Kitchen, M.; Comi, L.; Dragsted, U. B.; Clumeck, N.; Gatell, J.; Gazzard, B.; d’Arminio Monforte, A.; Rockstroh, J.; Yazdanpanah, Y.; Champenois, K.; Jakobsen, M. L.; Sullivan, A.; Lundgren, J. D. Više autora...

Citirajte ovaj rad

Raben, D., Mocroft, A., Rayment, M., Mitsura, V. M., Hadziosmanovic, V., Sthoeger, Z. M. ... Lundgren, J. D. (2015). Auditing HIV testing rates across Europe: results from the HIDES 2 Study. PLoS ONE, 10. (11). doi: 10.1371/journal.pone.0140845

Raben, D., et al. "Auditing HIV testing rates across Europe: results from the HIDES 2 Study." PLoS ONE, vol. 10, br. 11, 2015. https://doi.org/10.1371/journal.pone.0140845

Raben, D., A. Mocroft, M. Rayment, V. M. Mitsura, V. Hadziosmanovic, Z. M. Sthoeger, A. Palfreeman, et al. "Auditing HIV testing rates across Europe: results from the HIDES 2 Study." PLoS ONE 10, br. 11 (2015). https://doi.org/10.1371/journal.pone.0140845

Raben, D., et al. (2015) 'Auditing HIV testing rates across Europe: results from the HIDES 2 Study', PLoS ONE, 10(11). doi: 10.1371/journal.pone.0140845

Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, i sur.. Auditing HIV testing rates across Europe: results from the HIDES 2 Study. PLoS ONE [Internet]. 11.11.2015. [pristupljeno 11.04.2024.];10(11). doi: 10.1371/journal.pone.0140845

D. Raben, et al., "Auditing HIV testing rates across Europe: results from the HIDES 2 Study", PLoS ONE, vol. 10, br. 11, Studeni 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:804805. [Citirano: 11.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:804805
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Auditing HIV testing rates across Europe: results from the HIDES 2 Study
AutorD. Raben
AutorA. Mocroft
AutorM. Rayment
AutorV. M. Mitsura
AutorV. Hadziosmanovic
AutorZ. M. Sthoeger
AutorA. Palfreeman
AutorS. Morris
AutorG. Kutsyna
AutorA. Vassilenko
AutorJ. Minton
AutorC. Necsoi
AutorV. P. Estrada
AutorA. Grzeszczuk
AutorV. Svedhem Johansson
AutorJosip Begovac
AutorE. L. C. Ong
AutorA. Cabié
AutorF. Ajana
AutorB. M. Celesia
AutorF. Maltez
AutorM. Kitchen
AutorL. Comi
AutorU. B. Dragsted
AutorN. Clumeck
AutorJ. Gatell
AutorB. Gazzard
AutorA. d’Arminio Monforte
AutorJ. Rockstroh
AutorY. Yazdanpanah
AutorK. Champenois
AutorM. L. Jakobsen
AutorA. Sullivan
AutorJ. D. Lundgren
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
European guidelines recommend the routine offer of an HIV test in patients with a number of AIDS-defining and non-AIDS conditions believed to share an association with HIV; so called indicator conditions (IC). Adherence with this guidance across Europe is not known. We audited HIV testing behaviour in patients accessing care for a number of ICs. Participating centres reviewed the case notes of either 100 patients or of all consecutive patients in one year, presenting for each of the following ICs: tuberculosis, non-Hodgkins lymphoma, anal and cervical cancer, hepatitis B and C and oesophageal candidiasis. Observed HIV-positive rates were applied by region and IC to estimate the number of HIV diagnoses potentially missed. Outcomes examined were: HIV test rate (% of total patients with IC), HIV test accepted (% of tests performed/% of tests offered) and new HIV diagnosis rate (%). There were 49 audits from 23 centres, representing 7037 patients. The median test rate across audits was 72% (IQR 32-97), lowest in Northern Europe (median 44%, IQR 22-68%) and highest in Eastern Europe (median 99%, IQR 86-100). Uptake of testing was close to 100% in all regions. The median HIV+ rate was 0.9% (IQR 0.0-4.9), with 29 audits (60.4%) having an HIV+ rate >0.1%. After adjustment, there were no differences between regions of Europe in the proportion with >0.1% testing positive (global p = 0.14). A total of 113 patients tested HIV+. Applying the observed rates of testing HIV+ within individual ICs and regions to all persons presenting with an IC suggested that 105 diagnoses were potentially missed. Testing rates in well-established HIV ICs remained low across Europe, despite high prevalence rates, reflecting missed opportunities for earlier HIV diagnosis and care. Significant numbers may have had an opportunity for HIV diagnosis if all persons included in IC audits had been tested.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaPLoS ONE
Brojčani podacivol. 10, br. 11, e0140845
p-ISSN1932-6203
DOIhttps://doi.org/10.1371/journal.pone.0140845
URN:NBNurn:nbn:hr:105:804805
Datum objave publikacije2015-11-11
URL dokumentahttps://doi.org/10.1371/journal.pone.0140845
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 08:34:51